Sector
PharmaceuticalsOpen
₹280Prev. Close
₹287Turnover(Lac.)
₹8.34Day's High
₹280Day's Low
₹27552 Week's High
₹33952 Week's Low
₹144.1Book Value
₹57.15Face Value
₹10Mkt Cap (₹ Cr.)
319.68P/E
25.29EPS
11.35Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 11.5 | 11.5 | 8 | 5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 41.18 | 34.13 | -3.22 | -5.47 |
Net Worth | 52.68 | 45.63 | 4.78 | -0.47 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Gross Sales | 86.96 | 44.63 | 31.69 | 21.77 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 86.96 | 44.63 | 31.69 | 21.77 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 8.23 | 2.08 | 1.16 | 0.6 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Exec. Director
Hardik J Desai
Managing Director
Shravan Harikrishna Patel
Non Executive Director
Maniya H Desai
Independent Director
Mishal Shailesh Patel
Independent Director
Falguni Bhavesh Jariwala
Whole Time Director
Rupaben Chetanbhai Jariwala
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Trident Lifeline Ltd
Summary
Trident Lifeline Limited was originally incorporated as Private Limited Company under the name Trident Lifeline Private Limited on January 09, 2014. Subsequently, Company converted into a Public Limited pursuant to Shareholders Resolution on June 02, 2022 and name of Company was changed to Trident Lifeline Limited on June 10, 2022. The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It operate in India as well as African, Latin American and East Indian Countries. Presently, it has presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venezuela.Presently, Company operates with one contract manufacturer, who maintained relationship with the regular supplier, having FDA and WHO approved plant to supply pharma formulations. These units manufacture tablets, capsules, dry powder, syrup under their own brands. Pharma business operations are supported by various contract manufacturers having facilities which are approved by FDA/WHO and other relevant authorities. The Company typically work on contract manufacturing basis or at
Read More
The Trident Lifeline Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹278 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Trident Lifeline Ltd is ₹319.68 Cr. as of 09 May ‘25
The PE and PB ratios of Trident Lifeline Ltd is 25.29 and 5.02 as of 09 May ‘25
The 52-week high/low is the highest and lowest price at which a Trident Lifeline Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Trident Lifeline Ltd is ₹144.1 and ₹339 as of 09 May ‘25
Trident Lifeline Ltd's CAGR for 5 Years at N/I%, 3 Years at 38.45%, 1 Year at 79.82%, 6 Month at -7.64%, 3 Month at 6.30% and 1 Month at 8.71%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.